Dietrich A Stephan - Net Worth and Insider Trading
Dietrich A Stephan Net Worth
The estimated net worth of Dietrich A Stephan is at least $1 Million dollars as of 2024-04-25. Dietrich A Stephan is the President and CEO, 10% Owner of NeuBase Therapeutics Inc and owns about 2,560,164 shares of NeuBase Therapeutics Inc (NBSE) stock worth over $1 Million. Details can be seen in Dietrich A Stephan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dietrich A Stephan has not made any transactions after 2020-06-09 and currently still holds the listed stock(s).
Transaction Summary of Dietrich A Stephan
Dietrich A Stephan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dietrich A Stephan owns 1 companies in total, including NeuBase Therapeutics Inc (NBSE) .
Click here to see the complete history of Dietrich A Stephan’s form 4 insider trades.
Insider Ownership Summary of Dietrich A Stephan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBSE | NeuBase Therapeutics Inc | 2020-06-09 | director & 10 percent owner & President and CEO |
Dietrich A Stephan Latest Holdings Summary
Dietrich A Stephan currently owns a total of 1 stock. Dietrich A Stephan owns 2,560,164 shares of NeuBase Therapeutics Inc (NBSE) as of June 9, 2020, with a value of $1 Million.
Latest Holdings of Dietrich A Stephan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBSE | NeuBase Therapeutics Inc | 2020-06-09 | 2,560,164 | 0.42 | 1,077,829 |
Holding Weightings of Dietrich A Stephan
Dietrich A Stephan Form 4 Trading Tracker
According to the SEC Form 4 filings, Dietrich A Stephan has made a total of 3 transactions in NeuBase Therapeutics Inc (NBSE) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in NeuBase Therapeutics Inc is the acquisition of 1,275 shares on June 9, 2020, which cost Dietrich A Stephan around $9,856.
Insider Trading History of Dietrich A Stephan
- 1
Dietrich A Stephan Trading Performance
GuruFocus tracks the stock performance after each of Dietrich A Stephan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dietrich A Stephan is 8.84%. GuruFocus also compares Dietrich A Stephan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dietrich A Stephan within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dietrich A Stephan's insider trading performs compared to the benchmark.
Performance of Dietrich A Stephan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.83 | 8.84 | 3.16 | -28.63 | -62.91 | -72.12 |
| Relative Return to S&P 500(%) | 12.2 | -2.05 | -12.66 | -67.32 | -78.29 | -83.94 |
Dietrich A Stephan Ownership Network
Ownership Network List of Dietrich A Stephan
Ownership Network Relation of Dietrich A Stephan
Dietrich A Stephan Owned Company Details
What does NeuBase Therapeutics Inc do?
Who are the key executives at NeuBase Therapeutics Inc?
Dietrich A Stephan is the director & 10 percent owner & President and CEO of NeuBase Therapeutics Inc. Other key executives at NeuBase Therapeutics Inc include 10 percent owner Symetryx Corp , 10 percent owner Barry Shiff , and 10 percent owner Aleta Shiff .
NeuBase Therapeutics Inc (NBSE) Insider Trades Summary
Over the past 18 months, Dietrich A Stephan made no insider transaction in NeuBase Therapeutics Inc (NBSE). Other recent insider transactions involving NeuBase Therapeutics Inc (NBSE) include a net sale of 428,444 shares made by Symetryx Corp ,
In summary, during the past 3 months, insiders sold 0 shares of NeuBase Therapeutics Inc (NBSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 489,520 shares of NeuBase Therapeutics Inc (NBSE) were sold and 61,076 shares were bought by its insiders, resulting in a net sale of 428,444 shares.
NeuBase Therapeutics Inc (NBSE)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeuBase Therapeutics Inc Insider Transactions
Dietrich A Stephan Mailing Address
Above is the net worth, insider trading, and ownership report for Dietrich A Stephan. You might contact Dietrich A Stephan via mailing address: 213 Smithfield St, Pittsburgh Pa 15222.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
